Duncan Bucknell

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: Motion to German Parliament: No...

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: ‘No’ to Monsanto: Indian NGO...

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: FDA issues draft guidance on...

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: Canada: Supreme Court issues decision...

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: WHO, Gates, industry and NGO...

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: Algivon – UK: EWCA (Civ):...

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: UK: EWHC (Pat): “Obvious to...

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: CAFC: “Revisionist history is unpersuasive,”...

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: India yet to notify a...

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: EU: Further SPC granting guidelines...